Eden Research plc (LON:EDEN – Get Free Report) shares traded up 2.8% on Tuesday following insider buying activity. The stock traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares changed hands during trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).
Specifically, insider Alexander John Abrey purchased 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($26,902.58).
Eden Research Stock Performance
The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25. The stock has a market cap of £19.73 million, a P/E ratio of -200.00 and a beta of 0.92. The firm’s 50-day moving average is GBX 3.88 and its two-hundred day moving average is GBX 4.01.
Eden Research Company Profile
Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.
Further Reading
- Five stocks we like better than Eden Research
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- What is a support level?
- What Does the Future Hold for Eli Lilly?
- Why Invest in 5G? How to Invest in 5G Stocks
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.